Stem cell bank opens with backing from leading scientists. Is it worth the money?

Is it premature to start storing stem cells in the event they might be useful for treating diseases in the future?

The company’s roster of scientific advisers amounts to a who’s who of prominent stem cell experts, leading figures from Harvard and Stanford who are at the forefront of a field trying to turn basic discoveries into medical treatments of the future.

But instead of trying to develop new therapies itself, the company, LifeVault Bio, intends to store customers’ cells like treasured items in a well-sealed time capsule. The hope is that by preserving pristine cells before aging takes a toll on them, the cells could be used to treat customers should they one day develop heart disease or Parkinson’s or Alzheimer’s.

“We believe, and medicine is starting to believe, that this is really going to be a part of your health hygiene,” said LifeVault CEO Trevor Perry, predicting that stem cell banking will become as, as a form of “biological insurance”: “You insure a lot of things in your life, but have you taken out a policy on yourself?” Perry said.

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readScience
Pfizer Spends $11.4 Billion To Buy Array BioPharma For Its Cancer Drug Chemistry
Pfizer said it will spend $11.4 billion in cash to purchase Array BioPharma, a Boulder, Colo.-based biotech known as a top choice among biotechnology firms that need to synthesize new…
STAT4 min readSociety
Opinion: Ghost Networks Of Psychiatrists Make Money For Insurance Companies But Hinder Patients’ Access To Care
I tried calling a list of psychiatrists who supposedly took my insurance, but found a "ghost network" instead: Some were dead. Many weren't taking new patients. Others didn't take my…
STAT7 min readPolitics
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.